The Latin America, Middle East and Africa Mobile ECG Devices Market would witness market growth of 15.3% CAGR during the forecast period (2023-2030). In the year 2026, the LAMEA market's volume is expected to surge to 1,095.3 thousand units, showcasing a growth of 16.4% (2023-2030).
Wireless diagnostic tools such as WiFi, Bluetooth, and other wireless connections can transfer data from a mobile ECG device. Through connections with tablets, smartphones, and compatible apps, it exchanges, assesses, and saves data. Additionally, the development of user-friendly mobile ECG devices is a result of ongoing technological advancements. The improving features and usability of these devices are essential to the market's expansion. Furthermore, the market's growth is greatly aided by the rise in the elderly population. Because these devices are ideal for meeting the unique healthcare needs of the elderly, they are an essential part of healthcare programs designed with their needs in mind.
Recent years have seen a significant increase in the market for a variety of reasons, including the rising incidence of cardiovascular diseases, changing perspectives in healthcare, and advances in technology. Electrocardiography, a critical diagnostic tool for assessing cardiac health, has undergone a profound transformation with the introduction of these devices. These portable, user-friendly gadgets enable individuals to monitor their heart health conveniently, whether at home or on the go.
According to the World Heart Federation (WHF), 81% of all adult deaths in Argentina are attributable to noncommunicable diseases, including CVD. Over a third (35%) of these fatalities are caused by CVDs. Some of the most common CVD-related risk factors in adults in Argentina are smoking, drinking, hypertension, and obesity. One Argentinean consumes 9.3 liters of pure alcohol on average, and nearly a quarter (23%) of the population smokes tobacco. The WHF also reported that nearly a third (29.7%) of adults in Argentina are obese and that over a quarter (25.1%) have hypertension, which can raise the risk of heart failure, kidney disease, heart attack, or stroke.
Likewise, in the Middle East and North Africa, cardiovascular disease is the leading cause of death, accounting for more than one-third of all fatalities, or 1.4 million people annually. Cardiovascular diseases are responsible for between 40% of all deaths in Oman and 10% in Somalia. In the past 30 years, there has been an increase in CVD deaths of 48% overall. Additionally, between 2000 and 2019, the prevalence of obesity in the area more than doubled. As a result, there is a growing need for efficient systems to manage cardiovascular patient data and diagnostic information. Thus, as the LAMEA region continues to witness demographic, technological, and healthcare transformation, the adoption of mobile ECG devices is expected to rise.
The Brazil market dominated the LAMEA Mobile ECG Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $81.4 Million by 2030. The Argentina market is showcasing a CAGR of 16% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 15% during (2023 - 2030).
Based on Modality, the market is segmented into Handheld, Band, Pen, and Others. Based on End-use, the market is segmented into Hospitals & Diagnostic Centers, Ambulatory Care, and Homecare. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group), Nihon Kohden Corporation, GE HealthCare Technologies, Inc., Medtronic PLC, iRhythm Technologies, Inc., Koninklijke Philips N.V., OMRON Corporation, Nureca Limited (Dr Trust), EMAY, and AliveCor, Inc.
Wireless diagnostic tools such as WiFi, Bluetooth, and other wireless connections can transfer data from a mobile ECG device. Through connections with tablets, smartphones, and compatible apps, it exchanges, assesses, and saves data. Additionally, the development of user-friendly mobile ECG devices is a result of ongoing technological advancements. The improving features and usability of these devices are essential to the market's expansion. Furthermore, the market's growth is greatly aided by the rise in the elderly population. Because these devices are ideal for meeting the unique healthcare needs of the elderly, they are an essential part of healthcare programs designed with their needs in mind.
Recent years have seen a significant increase in the market for a variety of reasons, including the rising incidence of cardiovascular diseases, changing perspectives in healthcare, and advances in technology. Electrocardiography, a critical diagnostic tool for assessing cardiac health, has undergone a profound transformation with the introduction of these devices. These portable, user-friendly gadgets enable individuals to monitor their heart health conveniently, whether at home or on the go.
According to the World Heart Federation (WHF), 81% of all adult deaths in Argentina are attributable to noncommunicable diseases, including CVD. Over a third (35%) of these fatalities are caused by CVDs. Some of the most common CVD-related risk factors in adults in Argentina are smoking, drinking, hypertension, and obesity. One Argentinean consumes 9.3 liters of pure alcohol on average, and nearly a quarter (23%) of the population smokes tobacco. The WHF also reported that nearly a third (29.7%) of adults in Argentina are obese and that over a quarter (25.1%) have hypertension, which can raise the risk of heart failure, kidney disease, heart attack, or stroke.
Likewise, in the Middle East and North Africa, cardiovascular disease is the leading cause of death, accounting for more than one-third of all fatalities, or 1.4 million people annually. Cardiovascular diseases are responsible for between 40% of all deaths in Oman and 10% in Somalia. In the past 30 years, there has been an increase in CVD deaths of 48% overall. Additionally, between 2000 and 2019, the prevalence of obesity in the area more than doubled. As a result, there is a growing need for efficient systems to manage cardiovascular patient data and diagnostic information. Thus, as the LAMEA region continues to witness demographic, technological, and healthcare transformation, the adoption of mobile ECG devices is expected to rise.
The Brazil market dominated the LAMEA Mobile ECG Devices Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $81.4 Million by 2030. The Argentina market is showcasing a CAGR of 16% during (2023 - 2030). Additionally, The UAE market would register a CAGR of 15% during (2023 - 2030).
Based on Modality, the market is segmented into Handheld, Band, Pen, and Others. Based on End-use, the market is segmented into Hospitals & Diagnostic Centers, Ambulatory Care, and Homecare. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group), Nihon Kohden Corporation, GE HealthCare Technologies, Inc., Medtronic PLC, iRhythm Technologies, Inc., Koninklijke Philips N.V., OMRON Corporation, Nureca Limited (Dr Trust), EMAY, and AliveCor, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Modality (Volume, Thousand Units, USD Billion, 2019-2030)- Handheld
- Band
- Pen
- Others
- Hospitals & Diagnostic Centers
- Ambulatory Care
- Homecare
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group)
- Nihon Kohden Corporation
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- iRhythm Technologies, Inc.
- Koninklijke Philips N.V.
- OMRON Corporation
- Nureca Limited (Dr Trust)
- EMAY
- AliveCor, Inc.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Mobile ECG Devices Market, by Modality
Chapter 6. LAMEA Mobile ECG Devices Market, by End-use
Chapter 7. LAMEA Mobile ECG Devices Market, by Country
Chapter 8. Company Profiles
Companies Mentioned
- New York Plastic Surgical Group, PC (Long Island Plastic Surgical Group)
- Nihon Kohden Corporation
- GE HealthCare Technologies, Inc.
- Medtronic PLC
- iRhythm Technologies, Inc.
- Koninklijke Philips N.V.
- OMRON Corporation
- Nureca Limited (Dr Trust)
- EMAY
- AliveCor, Inc.
Methodology
LOADING...
